↓ Skip to main content

A novel RIP1/RIP3 dual inhibitor promoted OPC survival and myelination in a rat neonatal white matter injury model with hOPC graft

Overview of attention for article published in Stem Cell Research & Therapy, August 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A novel RIP1/RIP3 dual inhibitor promoted OPC survival and myelination in a rat neonatal white matter injury model with hOPC graft
Published in
Stem Cell Research & Therapy, August 2021
DOI 10.1186/s13287-021-02532-1
Pubmed ID
Authors

Chu Zhang, Qian Guan, Hao Shi, Lingsheng Cao, Jing Liu, Zixuan Gao, Wenxi Zhu, Yinxiang Yang, Zuo Luan, Ruiqin Yao

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 25%
Student > Bachelor 3 19%
Researcher 2 13%
Other 2 13%
Student > Doctoral Student 1 6%
Other 0 0%
Unknown 4 25%
Readers by discipline Count As %
Neuroscience 4 25%
Biochemistry, Genetics and Molecular Biology 2 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Veterinary Science and Veterinary Medicine 1 6%
Psychology 1 6%
Other 3 19%
Unknown 4 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 August 2021.
All research outputs
#13,749,545
of 23,310,485 outputs
Outputs from Stem Cell Research & Therapy
#1,002
of 2,453 outputs
Outputs of similar age
#192,447
of 432,543 outputs
Outputs of similar age from Stem Cell Research & Therapy
#26
of 95 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,453 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,543 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.